home / stock / nova:cc / nova:cc news

NOVA:CC News and Press, Nova Mentis Life Science Corp. From 01/18/23

Stock Information
Company Name: Nova Mentis Life Science Corp.
Stock Symbol: NOVA:CC
Market: CNQC
Menu
NOVA:CC NOVA:CC Quote NOVA:CC Short NOVA:CC News NOVA:CC Articles NOVA:CC Message Board
Get NOVA:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
NOVA:CC - Nova Mentis Appoints Derek Ivany as Executive Chairman

Vancouver, British Columbia--(Newsfile Corp. - January 18, 2023) - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company"), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics and complementary diagnostics for neuroin...
NOVA:CC - IIROC Trading Halt - NOVA

IIROC Trading Halt - NOVA Canada NewsWire VANCOUVER, BC , Dec. 22, 2022 /CNW/ - The following issues have been halted by IIROC: Company: Nova Mentis Life Science Corp. CSE Symbol: NOVA All Issues: Yes Reason: Pending News Halt Time (ET): 9:02 AM...

NOVA:CC - Nova Mentis' Psilocybin Preclinical Study Published in International Science Journal

Microdose Treatment Modulates Cognition Vancouver, British Columbia--(Newsfile Corp. - December 8, 2022) - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company"), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics ...

NOVA:CC - Nova Submits Phase II A Psilocybin Clinical Trial Application to Health Canada

Microdose Psilocybin Safety and Efficacy Clinical Study in Fragile X Syndrome Vancouver, British Columbia--(Newsfile Corp. - November 30, 2022) - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company"), a biotechnology company and global leader in first-...
NOVA:CC - Nova Mentis Enters into Research Contract with KGK Science for Phase II A Clinical Trial

Vancouver, British Columbia--(Newsfile Corp. - November 17, 2022) - Nova Mentis Life Science Corp. (CSE: NOVA) (OTCQB: NMLSF) (FSE: HN3Q) ("NOVA" or the "Company"), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics and complementary diagnostics for n...

NOVA:CC - Nova Mentis Psilocybin Microdose Capsule Formulation to be Submitted in Health Canada Phase 2A Clinical Trial Application

Vancouver, British Columbia--(Newsfile Corp. - September 29, 2022) - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company"), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics and complementary diagnostics for ne...

NOVA:CC - Nova Mentis Completes Production of Psilocybin Microdose Capsules

Company Plans to Submit Clinical Trial Application in Canada Vancouver, British Columbia--(Newsfile Corp. - September 15, 2022) - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company"), a biotechnology company and global leader in first-in-class psil...
NOVA:CC - Nova Mentis to Present Promising Psilocybin Microdose Data at 18th NFXF International Fragile X Conference

Vancouver, British Columbia--(Newsfile Corp. - July 11, 2022) - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company"), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics and complementary diagnostics for neuroin...

NOVA:CC - CEO's of BOXD, NEXCF, NMLSF, and SMFL Driving Innovation, and Revenue Growth Opportunities with Innovation in Web 3.0, E-Commerce, Baby Nutrition and Psychedelics-based Therapies

NEW YORK, June 23, 2022 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from CEO’s of: Boxed, Inc. (NYSE: BOXD), NexTech AR Solutions (OTC: NEXCF) (CSE: NTAR), Smart for Life (NASDAQ: S...

NOVA:CC - Nova Mentis to Present at the H.C. Wainwright Mental Health Conference

Vancouver, British Columbia--(Newsfile Corp. - June 22, 2022) - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company"), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics and complementary diagnostics for neuroin...
Previous 10 Next 10